NEWGENIV Stock

NIVF

VGG0544E3032

Market Closed - Nasdaq 16:00:00 2026-09-18 EDT			5-day change	1st Jan Change
0.7191 ^USD	+0.60%		-32.16%	-76.11%

24-04-02	A SPAC I Acquisition Corp.(NasdaqCM:ASCA) dropped from NASDAQ Composite Index	CI
24-04-02	NewGenIvf Limited completed the acquisition of A SPAC I Acquisition Corp. from A SPAC Acquisition Corp. and others in reverse merger transaction.	CI

A SPAC I Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus its search on the technology, media and telecom industries with a focus in the United States and/or Asia (excluding China). The Company has not commenced any operations nor generated any revenue.

Employees

Sector

More about the company

Quotes

Date	Price	Change
26-09-18	US$0.7191	+0.60%
26-09-17	US$0.7148	-8.93%
26-09-16	US$0.7849	-6.56%
26-09-15	US$0.8400	-9.60%
26-09-14	US$0.9292	-12.34%

Delayed Quote Nasdaq

More quotes

Market Cap	11.22M 9.78M 9.24M 8.39M 15.71M 1.08B 15.78M 111M 42.69M 547M 42.14M 41.2M 1.76B	P/E 2022	158x	P/E 2023	-85.7x
Enterprise Value	12.8M 11.16M 10.54M 9.57M 17.93M 1.23B 18M 126M 48.71M 624M 48.08M 47.01M 2.01B	EV / Sales 2022	-	EV / Sales 2023	-
Free-Float	-	Yield 2022 *	-	Yield 2023	-

24-04-02	A SPAC I Acquisition Corp.(NasdaqCM:ASCA) dropped from NASDAQ Composite Index	CI
24-04-02	NewGenIvf Limited completed the acquisition of A SPAC I Acquisition Corp. from A SPAC Acquisition Corp. and others in reverse merger transaction.	CI
24-03-29	A SPAC I Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-03-14	A SPAC I Acquisition Corp. announced that it has received $0.3 million in funding	CI
23-11-14	A SPAC I Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-08-17	A SPAC I Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-06-11	A SPAC I Acquisition Corp. announced that it has received $0.2 million in funding from A SPAC Acquisition Corp.	CI
23-05-11	A SPAC I Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
23-03-12	A SPAC I Acquisition Corp. announced that it has received $0.5 million in funding from A SPAC Acquisition Corp.	CI
23-03-03	A SPAC I Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
23-03-02	A SPAC I Acquisition Corp. Auditor Raises 'Going Concern' Doubt	CI
23-02-15	NewGenIvf Limited entered into a Merger Agreement to acquire A SPAC I Acquisition Corp. from A SPAC Acquisition Corp. and others in reverse merger transaction for $50 million.	CI
23-01-26	A SPAC I Acquisition Corp. announced that it has received $0.5 million in funding from A SPAC Acquisition Corp.	CI

08-17	NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor	AQ
07-30	NewGen Provides Update on K25.ai Investment and Strengthened Financial Position	AQ
07-27	NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million	AQ
07-23	NewGen’s Strategic Pre-A Investment in K25.ai Doubles in Value as K25.ai’s Valuation Reaches US$200 Million	AQ
07-06	NEWGENIV : NewGen’s Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 Million	PU

3 years	0.7	17.24
5 years	0	17.24
10 years	0	17.24

	2022	2023
Net sales	-	-
Net income	501K 437K 412K 374K 701K 48.04M 704K 4.94M 1.91M 24.42M 1.88M 1.84M 78.59M	-691K -602K -569K -517K -968K -66.29M -972K -6.81M -2.63M -33.7M -2.6M -2.54M -108M
Net Debt	-54.72K -47.71K -45.05K -40.91K -76.65K -5.25M -76.97K -540K -208K -2.67M -206K -201K -8.59M	1.58M 1.38M 1.3M 1.18M 2.22M 152M 2.23M 15.61M 6.02M 77.21M 5.95M 5.81M 248M

NEWGENIV Stock

Stocks

NIVF

VGG0544E3032

Valuation: NEWGENIV

Chart: NEWGENIV

Latest news: NEWGENIV

Press Releases: NEWGENIV

Quotes and Performance

Price Extremes

Financials

Company Profile

Quotes

1 day	+0.60%
Current month	-76.11%
Current year	-76.11%